1. Traws Pharma Secures $60M Lifeline, Aims for High-Stakes Flu Challenge Study This Summer
Traws Pharma is pushing forward with a critical $60 million financing round, a move that underscores the company's urgent need for capital to fund its ambitious clinical pipeline and extend its financial runway into early 2027. This financing is not merely an operational update; it is a decisive step to fuel a pivotal ...